CLINICAL_TRIALS
trial_result
· 2024-07-16
Clinical Trial Update: Open-label Extension Study to Evaluate Long-term Safety of Sacubitril/Valsartan in Pediatric Patients With HF [Phase 3]
Summary
Open-label extension study assessing long-term safety of sacubitril/valsartan in pediatric patients with heart failure; results posted in 2024.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Heart Failure | Phase 3 | Status: COMPLETED | Results posted: 2024-07-16